Heart failure risk assessment using biomarkers in patients with atrial fibrillation: analysis of 32,041 patients from the COMBINE-AF study

Back

ESC Professional Premium Access

Heart failure risk assessment using biomarkers in patients with atrial fibrillation: analysis of 32,041 patients from the COMBINE-AF study

Session: The interplay between atrial fibrillation and heart failure: implications for clinicians

Topic: Heart Failure in Atrial Fibrillation

Speaker: Doctor P. Haller (Boston, US)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Paul Michael Haller

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)

0 follower

5 more presentations in this session

Incidence of atrial fibrillation detected by an insertable cardiac monitor in a large real-world cohort of heart failure patients with reduced and preserved ejection fraction

Speaker: Mr S. Sarkar (Moundsview, US)

Long-term risk of heart failure and postoperative atrial fibrillation following noncardiac surgery: not so different from non-surgical atrial fibrillation

Speaker: Ms M. Karacan (Copenhagen, DK)

Prognostic implication of right ventricular - pulmonary arterial coupling in patients with non-valvular atrial fibrillation

Speaker: Assistant Professor D. Kim (Incheon, KR)

Prevalence and implications of cardiomyopathy-associated genetic variants in early-onset atrial fibrillation

Speaker: Miss L. Wijdeveld (Cambridge, US)

Atrial Fibrillation (AF) detected by repeat handheld ECG screening and the risk of heart failure hospitalization

Speaker: Doctor W. Sun (Shatin, HK)

Access the full session

The interplay between atrial fibrillation and heart failure: implications for clinicians

Speakers: Doctor P. Haller, Mr S. Sarkar, Ms M. Karacan, Assistant Professor D. Kim, Miss L. Wijdeveld...

Access

Video

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources